Physician profile
Deborah Charfoos
NPI 1154316776
$2,320.59
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $181 · 2021: $586 · 2022: $540 · 2023: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $240.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $650.96 | 2019-2023 | Orilissa |
| Amgen INC. | $237.83 | 2019-2022 | |
| Ascend Therapeutics US, LLC | $133.83 | 2021-2022 | |
| Pfizer INC. | $121.94 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $111.79 | 2019 | |
| Allergan, INC. | $93.88 | 2019-2021 | |
| Hologic Sales and Service, LLC | $90.27 | 2019-2023 | Acessa Provu System, Aptima |
| Organon LLC | $84.36 | 2021-2022 | |
| Daiichi Sankyo INC. | $83.93 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $83.54 | 2021-2023 | |
| Gynesonics, INC. | $71.59 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $62.57 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $57.31 | 2019 | |
| Astellas Pharma US INC | $55.48 | 2019-2023 | Myrbetriq, Veozah |
| Coopersurgical, INC. | $54.44 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $52.55 | 2019-2020 | |
| Aspira Women'S Health INC | $49.81 | 2022 | |
| Myovant Sciences INC. | $43.10 | 2021-2022 | |
| Evofem Biosciences, INC. | $42.08 | 2021 | |
| Mylan Pharmaceuticals INC. | $30.12 | 2020-2021 | |
| Exeltis, USA INC. | $23.70 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.44 | 2022 | |
| Merck Sharp & Dohme LLC | $16.77 | 2019 | |
| Virtus Pharmaceuticals LLC | $13.06 | 2021 | |
| Becton, Dickinson and Company | $12.37 | 2021 | |
| Acessa Health INC. | $12.07 | 2019 | |
| Vertical Pharmaceuticals, LLC | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Charfoos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.